MedTrace Logo

An ACT Based Application for Young People With Type 1 Diabetes

NCT02526069 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2016-05-12

No results posted yet for this study

Summary

Study Objectives:

This study aims to assess the feasibility and acceptability of an application utilising Acceptance and Commitment Therapy in young people with type 1 diabetes.

Primary Research Questions:

Is an ACT based application feasible and acceptable to young people with type 1 diabetes.

Study Design:

Patients will use the app for four weeks and then be invited to attend an interview discussing the acceptability, usability and feasibility of the app. Clinician's will also be invited to take part in a workshop where they interact with the app and provide feedback.

Consent for will be obtained through the app. Additional consent for the recording of interviews will be obtained in paper format and stored in a secure locked cabinet at Edinburgh University.

Quantitative data will also be collected on well-being, psychological flexibility, and data usage.

Data Collection

Qualitative feedback:

Interviews will be recorded and transcribed using unique identifiers.

Outcome measures and data usage patterns:

Data will be collected on a password protected database which can only be obtained via a password protected and encrypted server from University of Edinburgh.

Data Analysis:

Phase 1:

Framework analysis and interpretive phenomenological analysis will be utilised to create themes from the qualitative feedback.

Conditions

Interventions

BEHAVIORAL

Acceptance and Commitment Therapy

An application based on Acceptance and Commitment Therapy

Sponsors & Collaborators

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Estelle L Barker, MSc · University of Edinburgh

Study Design

Allocation
NA
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
13 Years
Max Age
22 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02526069 on ClinicalTrials.gov